Stockscreener 앱 받기
28.00
1.10%
0.3057
전일 마감가:
$27.70
열려 있는:
$27.79
하루 거래량:
1,512
Relative Volume:
0.28
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-1.02%
1개월 성능:
-2.91%
6개월 성능:
-7.13%
1년 성능:
-15.29%
1일 변동 폭
$27.79
$28.00
1주일 범위
$27.23
$28.01
52주 변동 폭
$25.32
$35.59
Tema Heart Health Etf Stock (HRTS) Company Profile
HRTS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HRTS
Tema Heart Health Etf
|
28.00 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
316.13 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
642.69 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
645.74 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
245.16 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
580.05 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Heart Health Etf 주식(HRTS)의 최신 뉴스
The stock price of Novo-Nordisk A/S plummeted by nearly 22%; what happened? - 富途牛牛
Short Interest in Tema Heart & Health ETF (NASDAQ:HRTS) Decreases By 62.5% - Defense World
OFS Credit Company, Inc. (NASDAQ:OCCIN) Sees Significant Decline in Short Interest - Defense World
First Trust S-Network E-Commerce ETF (NASDAQ:ISHP) Short Interest Down 91.7% in July - Defense World
Northern Graphite (CVE:NGC) Shares Up 42.1% – Time to Buy? - Defense World
5 Small-cap Biotech ETFs to Watch - Nasdaq
AMGEN AND FOOTBALL LEGEND BARRY SANDERS HIGHLIGHT DANGERS OF BAD CHOLESTEROL IN NEW DOCUMENTARY - Investing News Network
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177 - Investing News Network
Short Interest in Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Declines By 28.6% - Defense World
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Short Interest Down 60.0% in February - Defense World
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs - ETF Trends
Why the Rich World Is Going to Need AI and Africa - Bloomberg
Disruptive Theme of the Week: 2024's Top Investment Themes & Trends - ETF Trends
Tema's New VOLT ETF Sparked by AI Revolution - etf.com
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win - Nasdaq
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Nasdaq
Tap the Weight-Loss Drug Market With These ETFs - Nasdaq
Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says - CNBC
Disruptive Theme of the Week: The Rise of Active Thematic ETFs - ETF Trends
ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment - Yahoo Finance
ETF Innovators: 11 people disrupting the industry, creating unique products, and delivering mammoth returns - Business Insider
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO - markets.businessinsider.com
This ETF is trying to satisfy appetites for weight loss stocks - CNBC
ETF IQ: Mutual Fund Managers Have the Luxury to Just Say ‘No’ - Bloomberg
Investing in the diabesity epidemic: a breakthrough moment | Opto - CMC Markets
OZEM, Weight Loss Drug ETFs: Should You Invest? - etf.com
Obesity Market to Reach $150B as Demand Grows, Supply Stabilizes: Reuters - BioSpace
Weight-loss drug forecasts jump to $150 billion as supply grows - Reuters
Play These New ETFs to Tap Lucrative Weight Loss Drug Market - Yahoo Finance
Another thematic ETF launches to target global obesity battle - InvestmentNews
Fighting Obesity Using ETFs - ETF Trends
S&P 500: April Selloff Could Be a Very Good Thing for the Months Ahead - Investing.com India
IBD Stock Of The Day Pops After Obesity Drug Crushes Sales Views - Investor's Business Daily
What Is a Healthcare ETF? Everything You Need to Know - ETF.com
This weight-loss ETF has performed well. Here’s a look at other options. - MarketWatch
Is the global battle against obesity an opportunity for investors? - InvestmentNews
First Weight Loss ETF from Tema ETFs Announces Name Change, Tops $50 Million AUM - Markets Insider
Feisty Rivals Take On Eli Lilly, Novo Nordisk On Weight Loss - Investor's Business Daily
Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering - Value The Markets
LLY Stock: Study Highlights Weight Regain Risk with Lilly's Zepbound - Value The Markets
Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund - Reuters
The 5 Best Biotech ETFs of 2024 - etf.com
Tema Heart Health Etf (HRTS) 재무 분석
Tema Heart Health Etf (HRTS)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.01%
자본화:
|
볼륨(24시간):